Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01820819
Other study ID # AOM 10003
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 2012
Est. completion date September 30, 2016

Study information

Verified date June 2021
Source Assistance Publique - Hôpitaux de Paris
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine whether there are reasons other than medical reasons that could limit access to liver transplantation in alcoholic patients.


Description:

The investigators perform a study combining the follow up of a previous cohort of 450 patients and the inclusion of 150 new patients. The study is performed in medical or hepatogastroenterology departments of nine French public hospitals mostly non-teaching. They lay in three French area, selected according to the density of patients with alcoholic liver disease (ALD) in the area, respectively, "high" as in Brittany-Loire, 'average' in Ile de France and "low" as in the Languedoc-Roussillon. The patients included in the cohort must respond to the following criteria: having liver cirrhosis of whatever origin and age over 18 years. The cirrhosis must be confirmed by the morphological or histological criteria. Structured forms and questionnaires will allow the collection of data. Information collected from patients include socio demographic characteristics, medical history, history of consumption of psychotropic (i.e., alcohol or drugs), clinical, biological, histological characteristics and psychological. Inpatients complete a self-assessment structured questionnaire "Hospital Anxiety Depression Scale" (HAD). Patients are followed until they are registered or not on the national waiting list or die, every 6 months after inclusion until 2 years. Statistical analysis will focus on descriptive analysis, survival analysis by Kaplan-Meier, and analytic analysis. Association with registration on the national waiting list of inpatients will be searched using Cox and logistic regression models. Further analyzes will be conducted for example on the differences of opinion between physicians and patients, on regional differences.


Recruitment information / eligibility

Status Completed
Enrollment 574
Est. completion date September 30, 2016
Est. primary completion date September 30, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Inpatients - Age over 18 - Having liver cirrhosis of whatever origin (Cirrhosis was confirmed if morphological or histological criteria with or without esophageal varicoses were met) Exclusion Criteria: - Outpatients - Age less to 18 - With acute liver failure or hepatocarcinoma without liver cirrhosis

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Cochin Hospital Paris

Sponsors (2)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris Saint Antoine Hospital (Pr Yvon Camus)

Country where clinical trial is conducted

France, 

References & Publications (5)

Cohen C, Benjamin M. Alcoholics and liver transplantation. The Ethics and Social Impact Committee of the Transplant and Health Policy Center. JAMA. 1991 Mar 13;265(10):1299-301. — View Citation

Lucey MR, Beresford TP. Alcoholic liver disease: to transplant or not to transplant? Alcohol Alcohol. 1992 Mar;27(2):103-8. Review. — View Citation

Perut V, Conti F, Scatton O, Soubrane O, Calmus Y, Vidal-Trecan G. Might physicians be restricting access to liver transplantation for patients with alcoholic liver disease? J Hepatol. 2009 Oct;51(4):707-14. doi: 10.1016/j.jhep.2009.04.018. Epub 2009 May 28. — View Citation

Ubel PA. Transplantation in alcoholics: separating prognosis and responsibility from social biases. Liver Transpl Surg. 1997 May;3(3):343-6. — View Citation

Vidal-Trécan G, Kone V, Pilette C, Nousbaum JB, Doll J, Buffet C, Eugene C, Podevin P, Boutet O, Puyeo J, Conti F, Calmus Y. Subjective parameters markedly limit the referral of transplantation candidates to liver transplant centres. Liver Int. 2016 Apr;3 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Registration on the national waiting list 3 years
Secondary Potential candidate to liver transplantation according to the opinion of the caring physician on At the time of inpatients inclusion (previous study: fifth year after the first inclusion) At Day 0